Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats
- PMID: 9033268
- PMCID: PMC1858286
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats
Abstract
Advanced glycation end products (AGEs), formed from the nonenzymatic glycation of proteins and lipids with reducing sugars, have been implicated in many diabetic complications; however, their role in diabetic retinopathy remains largely unknown. Recent studies suggest that the cellular actions of AGEs may be mediated by AGE-specific receptors (AGE-R). We have examined the immunolocalization of AGEs and AGE-R components R1 and R2 in the retinal vasculature at 2, 4, and 8 months after STZ-induced diabetes as well as in nondiabetic rats infused with AGE bovine serum albumin for 2 weeks. Using polyclonal or monoclonal anti-AGE antibodies and polyclonal antibodies to recombinant AGE-R1 and AGE-R2, immunoreactivity (IR) was examined in the complete retinal vascular tree after isolation by trypsin digestion. After 2, 4, and 8 months of diabetes, there was a gradual increase in AGE IR in basement membrane. At 8 months, pericytes, smooth muscle cells, and endothelial cells of the retinal vessels showed dense intracellular AGE IR. AGE epitopes stained most intensely within pericytes and smooth muscle cells but less in basement membrane of AGE-infused rats compared with the diabetic group. Retinas from normal or bovine-serum-albumin-infused rats were largely negative for AGE IR. AGE-R1 and -R2 co-localized strongly with AGEs of vascular endothelial cells, pericytes, and smooth muscle cells of either normal, diabetic, or AGE-infused rat retinas, and this distribution did not vary with each condition. The data indicate that AGEs accumulate as a function of diabetes duration first within the basement membrane and then intracellularly, co-localizing with cellular AGE-Rs. Significant AGE deposits appear within the pericytes after long-term diabetes or acute challenge with AGE infusion conditions associated with pericyte damage. Co-localization of AGEs and AGE-Rs in retinal cells points to possible interactions of pathogenic significance.
Similar articles
-
Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.Microvasc Res. 2013 Nov;90:64-70. doi: 10.1016/j.mvr.2013.08.010. Epub 2013 Sep 5. Microvasc Res. 2013. PMID: 24012635
-
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8. Invest Ophthalmol Vis Sci. 2000. PMID: 11053301
-
Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.Int J Exp Pathol. 1998 Aug;79(4):207-22. Int J Exp Pathol. 1998. PMID: 9797717 Free PMC article.
-
Advanced glycation end-products and the progress of diabetic vascular complications.Physiol Res. 2004;53(2):131-42. Physiol Res. 2004. PMID: 15046548 Review.
-
[Advanced glycation end products (AGEs), free radicals and diabetes].J Soc Biol. 2001;195(4):387-90. J Soc Biol. 2001. PMID: 11938555 Review. French.
Cited by
-
Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy.Cells. 2024 Feb 29;13(5):429. doi: 10.3390/cells13050429. Cells. 2024. PMID: 38474393 Free PMC article.
-
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies.Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231205428. doi: 10.1177/14791641231205428. Diab Vasc Dis Res. 2023. PMID: 38116627 Free PMC article. Review.
-
Role of glycolysis in diabetic atherosclerosis.World J Diabetes. 2023 Oct 15;14(10):1478-1492. doi: 10.4239/wjd.v14.i10.1478. World J Diabetes. 2023. PMID: 37970130 Free PMC article. Review.
-
Posttranslational modifications of proteins in diseased retina.Front Cell Neurosci. 2023 Mar 30;17:1150220. doi: 10.3389/fncel.2023.1150220. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37066080 Free PMC article. Review.
-
Perivenular Capillary Rarefaction in Diabetic Retinopathy: Interdevice Characterization and Association to Clinical Staging.Ophthalmol Sci. 2023 Jan 3;3(2):100269. doi: 10.1016/j.xops.2023.100269. eCollection 2023 Jun. Ophthalmol Sci. 2023. PMID: 36875334 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources